Thyroid Support: Hashimoto's: What Far Infrared Can and Can't Do
We're not treating your thyroid.
We're supporting what runs around it.
The Honest Frame
If you're living with Hashimoto's thyroiditis or another form of thyroid dysfunction, you've probably already been told to try everything — diet changes, supplements, stress reduction. Far infrared sauna use gets recommended in this space often, and it's worth being direct about what that recommendation is actually built on before you spend time and money on it.
Far infrared does not treat Hashimoto's thyroiditis, hypothyroidism, or hyperthyroidism, and no controlled trial has tested it as a thyroid therapy. What it does have evidence for — circulation, systemic inflammation pathways, and general stress physiology — may be relevant to how you feel day to day with this condition, even though none of it targets the thyroid gland itself or your antibody levels.
What the Evidence Actually Supports
Circulation and vascular signaling. Far infrared exposure drives NRF2-mediated signaling — including NOS3, the enzyme responsible for nitric-oxide-driven vasodilation — shown in a heat-controlled randomized trial to be mechanism-specific rather than simply a byproduct of thermal load (Bagabir et al. 2025, Free Radic Biol Med). The thyroid is one of the most highly vascularized organs in the body; whether improved general circulation meaningfully affects thyroid tissue specifically has not been tested.
Inflammatory signaling. Animal-model gene expression studies show FIR downregulates NF-κB and related inflammatory pathways (Chen et al. 2022, J Adv Res), the same signaling implicated in the immune activity that drives Hashimoto's. Human trial data on FIR/heat exposure and inflammatory markers are honestly mixed — supportive in one hyperthermia study in an autoimmune population (Tarner 2009, Clin Rheumatol, ankylosing spondylitis), null on cytokine change in another (Langhorst 2023, J Clin Med, fibromyalgia). No study has measured this specifically in Hashimoto's or thyroid antibody levels.
Stress and autonomic regulation. Hashimoto's fatigue and brain fog overlap heavily with symptoms responsive to general parasympathetic/stress-modulation effects seen in whole-body hyperthermia research (Janssen et al. 2016, JAMA Psychiatry). This is a plausible route to feeling better day-to-day — not a mechanism that touches thyroid hormone production or autoimmune activity.
What Is Not Established
NOT ESTABLISHEDThyroid antibody reduction, hormone normalization, or heavy-metal-driven thyroid "detox." No controlled trial has shown far infrared sauna use lowers TPO or thyroglobulin antibodies, normalizes TSH/T3/T4, or reverses thyroid tissue damage. Claims connecting sweat-based heavy metal excretion to thyroid autoimmune improvement chain together two separately-studied ideas — sweat can carry certain heavy metals (Genuis et al. 2011, 2012), and some heavy metals are associated with thyroid disruption in other research — but no study has tested whether sauna-driven sweating changes thyroid outcomes. That chain is plausible, not demonstrated.
Heat Intolerance Is a Real Medical Sign — Not a Reason to Push Through
- Heat intolerance is a hallmark clinical symptom of hyperthyroidism and thyroid storm. If you experience racing heartbeat, tremor, unusual anxiety, or heat intolerance with a known or suspected overactive thyroid, sauna use is not appropriate until this is evaluated.
- Hashimoto's can include a transient hyperthyroid phase ("Hashitoxicosis") even in patients usually managed for hypothyroidism — if your symptoms or labs have shifted recently, check with your endocrinologist before resuming sauna sessions.
- Thyroid medication (levothyroxine, antithyroid drugs) dosing is not adjusted based on sauna use, and sauna use is not a substitute for medication.
Talk to Your Endocrinologist First If You Have:
Uncontrolled hyperthyroidism, recent thyroid storm history, cardiac arrhythmia associated with thyroid disease, or pregnancy with thyroid disease. Well-managed hypothyroidism on stable medication is generally the population where general FIR use (as described above) carries the fewest special considerations — but this is not medical clearance, and your own clinician knows your case.
Putting FIR in Perspective
Approach this the way you'd approach any general wellness tool: one part of a broader picture that includes your actual thyroid treatment, not a replacement for any part of it. If circulation, inflammation, or stress support sound relevant to how you're feeling, that's a reasonable reason to try it. "It will fix my thyroid" is not — and nobody offering you that claim is reading the same research we just walked through.
Want the full mechanistic breakdown, including the seasonal TSH-temperature relationship and where the thyroid-gut-inflammation literature actually stands? See our companion Clinical Science Brief for practitioners.
Read the Clinical Science Brief ↓
Sources: Bagabir et al. 2025 (Free Radic Biol Med); Chen et al. 2022 (J Adv Res 38:107-118); Tarner 2009 (Clin Rheumatol); Langhorst 2023 (J Clin Med); Janssen et al. 2016 (JAMA Psychiatry); Genuis et al. 2011 (Arch Environ Contam Toxicol), 2012 (Sci World J).
Medical Professional Facing Page
Far Infrared Therapy and Thyroid Autoimmune Disease
A Mechanistic Review with Explicit Boundaries on Hashimoto's Thyroiditis
Relax Saunas Clinical Science Series
Overview
Hashimoto's thyroiditis is the most common autoimmune thyroid disorder and the leading cause of hypothyroidism in iodine-sufficient regions, driven by lymphocytic infiltration and antibody-mediated destruction of thyroid tissue (Ragusa et al. 2019, as cited in recent reviews). Patients and practitioners increasingly encounter far infrared (FIR) sauna use recommended as a complementary tool for thyroid conditions. This review evaluates the actual evidence base for that recommendation, distinguishes mechanism-transferred plausibility from direct clinical evidence, and states explicitly where no evidence exists.
No controlled trial has evaluated far infrared therapy specifically in a thyroid or Hashimoto's population. Every mechanism discussed below is transferred from general circulatory, inflammatory, or stress-physiology literature — not thyroid-specific data. This review's purpose is to state clearly which extrapolations are reasonable, which are speculative, and which safety considerations are non-negotiable.
Background: Hashimoto's Pathophysiology
Hashimoto's thyroiditis involves a breakdown of immune tolerance to thyroid autoantigens — principally thyroid peroxidase (TPO) and thyroglobulin (Tg) — leading to lymphocytic infiltration and progressive follicular destruction (Mundorf-adjacent literature; see thyroid-gut axis reviews). The immunopathogenesis is driven substantially by Th1-mediated responses with elevated interferon-γ production and impaired regulatory T-cell function, alongside proposed environmental triggers including viral infection, iodine intake, and gut dysbiosis affecting deiodinase activity and TSH regulation.
A well-established, non-FIR-related endocrine phenomenon is seasonal TSH variation: TSH concentrations trend higher in colder months and lower in warmer months across multiple population cohorts, reflecting the hypothalamic-pituitary-thyroid axis's general sensitivity to ambient and core body temperature. This establishes plausibility that thermal exposure interacts with thyroid axis physiology in some form — it does not establish that FIR-specific heat exposure produces a clinically meaningful or directional effect.
Mechanistic Rationale
Circulatory and Vascular Signaling
FIR exposure activates NRF2-mediated signaling — including NOS3, TXNRD1, and HSP70 — shown in a heat-controlled, three-arm randomized trial to be mechanism-specific rather than a simple byproduct of thermal load (Bagabir et al. 2025, Free Radic Biol Med). The thyroid is among the most highly vascularized organs in the body per unit mass; improved systemic perfusion is mechanistically plausible as relevant to thyroid tissue oxygenation and hormone synthesis substrate delivery. This has not been directly measured in thyroid tissue in any human FIR trial.
Inflammatory Pathway Modulation
Animal-model gene expression data demonstrate FIR downregulates NF-κB, MAPK, and PI3K-Akt inflammatory signaling in an adjuvant-induced arthritis model (Chen et al. 2022, J Adv Res), pathways also implicated in Th1-driven autoimmune thyroid destruction. Human trial data on FIR/heat exposure and inflammatory cytokines in autoimmune populations are mixed: whole-body hyperthermia reduced TNF-α, IL-1β, and IL-6 in ankylosing spondylitis (Tarner 2009, Clin Rheumatol, supportive), while a wIRA whole-body-hyperthermia RCT in fibromyalgia found reduced pain but no significant cytokine change, with IL-6 rising transiently (Langhorst 2023, J Clin Med, the honest counterweight). Neither trial enrolled thyroid autoimmune patients or measured TPO/Tg antibodies.
Autonomic and Stress Physiology
Whole-body hyperthermia has shown antidepressant effects in a sham-controlled RCT (Janssen et al. 2016, JAMA Psychiatry), and fatigue/cognitive symptoms in Hashimoto's overlap substantially with symptoms responsive to general stress-axis modulation. This is a plausible route to improved subjective wellbeing in thyroid patients — it does not constitute evidence of any effect on thyroid hormone production, conversion, or autoimmune activity.
Domains of Insufficient Evidence
Explicit Position: What Is Not Supported
- No controlled trial has measured FIR's effect on TPO antibody, thyroglobulin antibody, TSH, free T4, or free T3 levels in any human population.
- No trial has evaluated FIR sauna use as a treatment for Hashimoto's thyroiditis, hypothyroidism, hyperthyroidism, or Graves' disease.
- The frequently circulated claim that FIR-driven sweat excretion of heavy metals (mercury, lead, cadmium) improves thyroid autoimmune activity chains together two independently studied but never jointly tested findings: sweat can carry certain heavy metals (Genuis et al. 2011, 2012), and heavy metal exposure is associated with thyroid disruption in separate observational literature. No study has tested whether FIR-induced sweating changes thyroid clinical or serological outcomes. This chain should be represented to patients as a hypothesis, not a demonstrated mechanism.
- Thyroid-gut-axis and dysbiosis literature (Knezevic 2020; Golan et al. 2013) is unrelated to FIR mechanism and should not be conflated with it in patient-facing materials.
Safety Considerations — Non-Negotiable
Heat Intolerance and Thyrotoxicosis Risk
- Heat intolerance is a hallmark clinical sign of hyperthyroidism and impending thyroid storm. Patients with uncontrolled hyperthyroidism, tachyarrhythmia associated with thyroid disease, or recent thyroid storm history should not use FIR sauna therapy pending endocrinology clearance.
- Hashimoto's thyroiditis can present with a transient hyperthyroid phase ("Hashitoxicosis") even in patients typically managed for hypothyroidism. New or changing symptoms (palpitations, tremor, unexplained anxiety, heat intolerance) warrant re-evaluation before continued sauna use.
- Thyroid medication dosing (levothyroxine, antithyroid agents) is not adjusted on the basis of sauna use, and FIR therapy should never be positioned as a substitute for pharmacologic management.
- Pregnancy with active thyroid disease warrants obstetric and endocrinology co-management before any heat-therapy recommendation.
Evidence Grading Summary
| Domain | Mechanism Evidence | Human Evidence | Tier |
|---|---|---|---|
| Circulatory support | Strong (NRF2/NOS3, RCT-demonstrated, heat-independent) | Not measured in thyroid tissue | Mechanistic Only |
| Inflammatory modulation | Strong (animal model, direct FIR) | Mixed (non-thyroid autoimmune populations) | Preliminary |
| Stress/autonomic support | Moderate (WBH literature) | Positive (non-thyroid populations) | Preliminary |
| Thyroid antibody / hormone change | None specific to thyroid | None — no trials conducted | Absent |
| Heavy-metal-mediated thyroid improvement | Two unconnected literatures | None — chain untested | Absent / Speculative |
Clinical Positioning
Far infrared therapy should be positioned to thyroid patients as supportive general physiology — circulation, systemic inflammation modulation, and stress-axis support — never as a thyroid-targeted or disease-modifying intervention. Patients should be screened for hyperthyroid symptoms and thyroid stability before recommending sauna use, and heat intolerance reported by a thyroid patient should prompt medical evaluation rather than reassurance to continue.
References
Bagabir, R. et al. (2025). Heat-controlled trial of far infrared exposure and NRF2-mediated vascular signaling. Free Radic Biol Med.
Chen, Y. et al. (2022). Far-infrared radiation modulates inflammatory gene expression in adjuvant-induced arthritis. J Adv Res, 38, 107-118.
Genuis, S.J. et al. (2011). Blood, urine, and sweat study: monitoring and elimination of bioaccumulated toxic elements. Arch Environ Contam Toxicol, 61(2), 344-357.
Genuis, S.J. et al. (2012). Blood, urine, and sweat study: monitoring and elimination of perfluorinated compounds. Sci World J, 2012, 615068.
Janssen, C.W. et al. (2016). Whole-body hyperthermia for the treatment of major depressive disorder. JAMA Psychiatry, 73(8), 789-795.
Langhorst, J. et al. (2023). Whole-body hyperthermia in fibromyalgia: a randomized controlled trial. J Clin Med.
Tarner, I.H. et al. (2009). Whole-body hyperthermia in ankylosing spondylitis. Clin Rheumatol.
Explore the Relax Far Infrared Line Up
Feel the Momentum
